Uptrend Call Working As Progenics Pharmaceuticals Stock Rises 19.8% (PGNX)

SmarTrend identified an Uptrend for Progenics Pharmaceuticals (NASDAQ:PGNX) on July 8th, 2016 at $5.49. In approximately 3 months, Progenics Pharmaceuticals has returned 19.78% as of today's recent price of...